These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 20800513)
1. Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection. Lin HH; Ke HL; Wu WJ; Lee YH; Chang LL Urol Oncol; 2012; 30(2):177-81. PubMed ID: 20800513 [TBL] [Abstract][Full Text] [Related]
2. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628 [TBL] [Abstract][Full Text] [Related]
3. Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. Lin HH; Ke HL; Huang SP; Wu WJ; Chen YK; Chang LL Urol Oncol; 2010; 28(6):597-602. PubMed ID: 19181545 [TBL] [Abstract][Full Text] [Related]
4. Frequency of P16INK4a and P14ARF genes methylation and its impact on bladder cancer cases in north Indian population. Ali Hosseini S; Sobti RC; Malekzadeh K; Singh SK; Joshi K Dis Markers; 2010; 28(6):361-8. PubMed ID: 20683150 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310 [TBL] [Abstract][Full Text] [Related]
8. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703 [TBL] [Abstract][Full Text] [Related]
9. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer. Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer. Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877 [TBL] [Abstract][Full Text] [Related]
11. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Krassenstein R; Sauter E; Dulaimi E; Battagli C; Ehya H; Klein-Szanto A; Cairns P Clin Cancer Res; 2004 Jan; 10(1 Pt 1):28-32. PubMed ID: 14734448 [TBL] [Abstract][Full Text] [Related]
12. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Gutiérrez MI; Siraj AK; Khaled H; Koon N; El-Rifai W; Bhatia K Mod Pathol; 2004 Oct; 17(10):1268-74. PubMed ID: 15154012 [TBL] [Abstract][Full Text] [Related]
13. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019 [TBL] [Abstract][Full Text] [Related]
14. Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine. Chen PC; Tsai MH; Yip SK; Jou YC; Ng CF; Chen Y; Wang X; Huang W; Tung CL; Chen GC; Huang MM; Tong JH; Song EJ; Chang DC; Hsu CD; To KF; Shen CH; Chan MW BMC Med Genomics; 2011 May; 4():45. PubMed ID: 21599969 [TBL] [Abstract][Full Text] [Related]
15. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients. Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel. Brücher BL; Geddert H; Langner C; Höfler H; Fink U; Siewert JR; Sarbia M Int J Cancer; 2006 Sep; 119(6):1298-302. PubMed ID: 16619216 [TBL] [Abstract][Full Text] [Related]
17. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Chan MW; Chan LW; Tang NL; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF Int J Cancer; 2003 May; 104(5):611-6. PubMed ID: 12594816 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210 [TBL] [Abstract][Full Text] [Related]
19. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma. Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]